Brief: Enorama Pharma Names Amy Walker New Interim CEO
15/07/2026 13:57
BRIEF-Enorama Pharma Names Amy Walker New Interim CEO July 15 (Reuters) - Enorama Pharma AB ERMA.ST:
BENGT JÖNSSON RESIGNS FROM ALL ASSIGNMENTS WITH IMMEDIATE EFFECT
APPOINTS AMY WALKER AS INTERIM CEO WITH IMMEDIATE EFFECT
Source text: ID:nWkr7B1n3y
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO